Data to substantiate these concerns were lacking in normal condition of use, in the context of what is required in Article 116 of Directive 2001/ 83/ EC, as amended and CPMP agreed to introduce adequate warnings and precautions in the SPC, this included limiting the indication to seasonal rhinitis to reduce the duration of treatment.